Arnhold LLC Abb Vie Inc. Transaction History

Arnhold LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $12.2 Million - $15.1 Million	-92,490 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$107.43 - $135.93 $4.57 Million - $5.79 Million	-42,575 Reduced 31.52%	92,490 $12.5 Million
Q3 2021 Oct 19, 2021	SELL	$106.4 - $120.78 $3.8 Million - $4.31 Million	-35,707 Reduced 20.91%	135,065 $14.6 Million
Q2 2021 Aug 04, 2021	SELL	$105.21 - $117.21 $5.22 Million - $5.81 Million	-49,576 Reduced 22.5%	170,772 $19.2 Million
Q1 2021 Apr 30, 2021	SELL	$102.3 - $112.62 $1.79 Million - $1.97 Million	-17,500 Reduced 7.36%	220,348 $23.8 Million
Q4 2020 Feb 08, 2021	BUY	$80.49 - $108.67 $4.91 Million - $6.63 Million	60,976 Added 34.47%	237,848 $25.5 Million
Q2 2020 Aug 03, 2020	BUY	$73.37 - $98.18 $3.8 Million - $5.08 Million	51,731 Added 41.34%	176,872 $17.4 Million
Q1 2020 Apr 17, 2020	BUY	$64.5 - $97.79 $2.99 Million - $4.54 Million	46,418 Added 58.96%	125,141 $9.53 Million
Q4 2019 Feb 05, 2020	SELL	$72.13 - $90.25 $751,089 - $939,773	-10,413 Reduced 11.68%	78,723 $6.97 Million
Q3 2019 Oct 29, 2019	BUY	$62.98 - $75.72 $956,855 - $1.15 Million	15,193 Added 20.55%	89,136 $6.75 Million
Q2 2019 Aug 08, 2019	BUY	$65.7 - $83.98 $4.86 Million - $6.21 Million	73,943 New	73,943 $5.38 Million

3,891

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $325B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Arnhold LLC, based on Form 13F filings with the SEC.

Stay updated on Arnhold LLC with notifications on news.